Struggling With Great Stock Picks? Discover StockInvest.us Top Gems!

Range Low Price High Price Comment
30 days $38.60 $44.37 Friday, 10th May 2024 XENE stock ended at $40.54. This is 4.59% less than the trading day before Thursday, 9th May 2024. During the day the stock fluctuated 10.26% from a day low at $38.60 to a day high of $42.56.
90 days $38.60 $50.99
52 weeks $27.99 $50.99

Historical Xenon Pharmaceuticals Inc. prices

Date Open High Low Close Volume
Jul 26, 2023 $36.44 $37.10 $35.42 $35.80 344 627
Jul 25, 2023 $36.25 $37.12 $36.04 $36.49 317 041
Jul 24, 2023 $37.13 $37.13 $36.16 $36.39 447 670
Jul 21, 2023 $38.03 $38.05 $36.86 $37.01 268 549
Jul 20, 2023 $39.12 $39.31 $37.84 $37.88 348 092
Jul 19, 2023 $39.24 $39.50 $38.55 $39.15 182 419
Jul 18, 2023 $39.09 $39.32 $38.44 $39.05 248 336
Jul 17, 2023 $39.02 $40.04 $39.02 $39.12 349 165
Jul 14, 2023 $38.17 $38.87 $37.51 $38.85 179 430
Jul 13, 2023 $38.70 $39.04 $38.06 $38.09 243 538
Jul 12, 2023 $39.94 $39.94 $38.06 $38.70 328 226
Jul 11, 2023 $38.49 $39.72 $38.18 $39.64 176 254
Jul 10, 2023 $38.63 $39.04 $38.31 $38.59 214 613
Jul 07, 2023 $38.95 $39.36 $38.28 $38.70 261 106
Jul 06, 2023 $38.02 $39.17 $37.87 $38.92 201 200
Jul 05, 2023 $38.33 $38.99 $37.88 $38.45 140 409
Jul 03, 2023 $38.41 $39.34 $38.00 $38.25 157 553
Jun 30, 2023 $38.73 $39.32 $38.34 $38.50 240 794
Jun 29, 2023 $40.39 $41.31 $38.27 $38.43 246 172
Jun 28, 2023 $40.21 $40.50 $39.61 $40.47 269 097
Jun 27, 2023 $38.97 $40.22 $38.53 $40.11 582 088
Jun 26, 2023 $39.89 $41.32 $38.95 $39.03 247 249
Jun 23, 2023 $40.34 $40.52 $39.91 $40.01 293 062
Jun 22, 2023 $41.45 $41.91 $40.63 $40.67 178 003
Jun 21, 2023 $40.96 $41.70 $40.46 $41.67 229 810
Click to get the best stock tips daily for free!

About Xenon Pharmaceuticals Inc.

Xenon Pharmaceuticals. Xenon Pharmaceuticals Inc., a clinical-stage biopharmaceutical company, engages in developing therapeutics to treat patients with neurological disorders in Canada. Its clinical development pipeline includes XEN496, A Kv7 potassium channel opener that is Phase III clinical trials for the treatment of KCNQ2 developmental and epilepsy encephalopathy; and XEN1101, A Kv7 potassium channel opener, which is in Phase II clinical trial for the treatment o... XENE Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT